Clinical Efficacy Study of Tolvaptan on Patients with Autosomal Dominant Polycystic Kidney Disease
Phase 4
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- Registration Number
- JPRN-UMIN000015715
- Lead Sponsor
- Kyorin University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who did not or will not give consent to participate to the study protocol. 2)Patients who is considered to be excluded by physicians.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Annual change rate of Total Kidney Volume (TKV slope; ml/year, % /year)
- Secondary Outcome Measures
Name Time Method Annual change rate of eGFR (eGFR slope; ml/min/1.73m2 per year) which is estimated by creatinine and cystatin-C.